Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT01789320
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of non-infectious intermediate, posterior or pan-uveitis
Exclusion Criteria:
* any ocular trauma within the past 6 months in the study eye
* any injection of intraocular corticosteroids or steroid implant or the Ozurdex® implant in the 6 months prior to the study treatment, or any prior use of Retisert™ in the study eye
* any uncontrolled systemic disease that would preclude participation in the study or put the subject at risk due to study treatment or procedures
* have a known HIV infection or other immunodeficiency disease for which corticosteroid therapy would be contraindicated
* are monocular
* have ocular hypertension
* history of any intraocular surgery in the study eye
* presence of an anterior staphyloma in the study eye
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01789320
Study Brief:
Protocol Section:
NCT01789320